![Neil Gunn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil Gunn
Directeur/Membre du Conseil chez
NEOGENOMICS, INC.
Fortune : 538 382 $ au 31/05/2026
Profil
Dr. Neil Gunn is an Independent Director at NeoGenomics, Inc., an Independent Director at Rarecells, Inc. and an Independent Director at Alveo Technologies, Inc. He is on the Board of Directors at NeoGenomics, Inc., Rarecells, Inc., Alveo Technologies, Inc. and Rarecells Diagnostics SAS. Dr. Gunn was previously employed as a Chief Executive Officer & Director by IDbyDNA, Inc., a Non-Executive Director by Genetic Signatures Ltd., a President by Roche Sequencing Solutions, Inc., a Vice President-Commercial Operations by CaridianBCT, Inc., a Vice President-Commercial Operations by Novartis Vaccines & Diagnostics SL, and a Head-Global Business by Roche Molecular Systems, Inc. He received his undergraduate degree from Nottingham Trent University, a graduate degree from the University of Portsmouth and a doctorate degree from the University of Portsmouth.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NEOGENOMICS, INC. 0,04% | 01/06/2026 | 51 177 ( 0,04% ) | 538 382 $ | 31/05/2026 |
| 08/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Neil Gunn
| Sociétés | Poste | Début |
|---|---|---|
| NEOGENOMICS, INC. | Directeur/Membre du Conseil | 26/06/2023 |
Alveo Technologies, Inc.
 Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices | Directeur/Membre du Conseil | 13/05/2021 |
Rarecells USA, Inc.
 Rarecells USA, Inc. Packaged SoftwareTechnology Services Develops and commercializes technology to isolate circulating cancer cells for early cancer diagnosis and medical research | Directeur/Membre du Conseil | 06/09/2022 |
Rarecells Diagnostics SAS
 Rarecells Diagnostics SAS Packaged SoftwareTechnology Services Develops and commercializes ISET technology to isolate circulating cancer cells for early cancer diagnosis & medical research | Directeur/Membre du Conseil | - |
Anciens postes connus de Neil Gunn
| Sociétés | Poste | Fin |
|---|---|---|
| GENETIC SIGNATURES LIMITED | Directeur Général | 30/09/2024 |
IDbyDNA, Inc.
 IDbyDNA, Inc. BiotechnologyHealth Technology Develops technologies that will enable nucleic acid based identification testing services | Directeur Général | 01/01/2022 |
CaridianBCT, Inc.
 CaridianBCT, Inc. Medical/Nursing ServicesHealth Services Designs, develops and supplies blood components | Corporate Officer/Principal | - |
Novartis Vaccines & Diagnostics SL | Corporate Officer/Principal | - |
Roche Molecular Systems, Inc.
 Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Develops & produces molecular-based diagnostic tests & automated testing platforms | Corporate Officer/Principal | - |
Formation de Neil Gunn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
NeoGenomics, Inc.
 NeoGenomics, Inc. Medical/Nursing ServicesHealth Services Provides genetic and molecular testing services | Health Services |
Nottingham Trent University
 Nottingham Trent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CaridianBCT, Inc.
CaridianBCT, Inc. Medical/Nursing ServicesHealth Services Designs, develops and supplies blood components | Health Services |
Genetic Signatures Ltd.
 Genetic Signatures Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes diagnostic kits | Commercial Services |
University of Portsmouth
 University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Develops & produces molecular-based diagnostic tests & automated testing platforms | Health Services |
Novartis Vaccines & Diagnostics SL | |
Rarecells USA, Inc.
Rarecells USA, Inc. Packaged SoftwareTechnology Services Develops and commercializes technology to isolate circulating cancer cells for early cancer diagnosis and medical research | Technology Services |
IDbyDNA, Inc.
IDbyDNA, Inc. BiotechnologyHealth Technology Develops technologies that will enable nucleic acid based identification testing services | Health Technology |
Alveo Technologies, Inc.
Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices | Health Technology |
Roche Sequencing Solutions, Inc.
 Roche Sequencing Solutions, Inc. Medical/Nursing ServicesHealth Services Provides diagnostics and treatments services | Health Services |
Rarecells Diagnostics SAS
Rarecells Diagnostics SAS Packaged SoftwareTechnology Services Develops and commercializes ISET technology to isolate circulating cancer cells for early cancer diagnosis & medical research | Technology Services |
